General Information of the Compound
Compound ID |
CP0456107
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1'-[2-[4-(2-chlorophenyl)piperazin-1-yl]ethyl]spiro[1H-indole-3,3'-pyrrolidine]-2-one
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C23H27ClN4O
|
||||||||||||||||||
Molecular Weight |
410.949
|
||||||||||||||||||
Canonical SMILES |
Clc1ccccc1N1CCN(CCN2CCC3(C2)C(=O)Nc2ccccc32)CC1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C23H27ClN4O/c24-19-6-2-4-8-21(19)28-15-13-26(14-16-28)11-12-27-10-9-23(17-27)18-5-1-3-7-20(18)25-22(23)29/h1-8H,9-17H2,(H,25,29)
Show/Hide
|
||||||||||||||||||
InChIKey |
MURZWGBCAWAQPT-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7